Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2022-05-20
2023-04-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Despite the large number of published studies on taste and smell alterations in diverse cancer populations, few have examined other dimensions of oral sensory alterations. Studies focusing on somesthesia have mostly been conducted in the area of oral physiology or stomatology in relation to oral pain and rehabilitation (Howes, Wongsriruksa, Laughlin, Witchel, \& Miodownik, 2014).
Regarding food perception, somesthesia provides information about both texture, temperature, and trigeminal sensations. These sensations are detected by mechanical, thermal, nociceptive receptors present throughout the oral epithelium (Simons \& Carstens, 2008). In addition to taste and smell, food perception is influenced by oral somatosensation and studies have demonstrated an interrelated relationship between these oral sensations (Spence, Piqueras-Fiszman 2016). Therefore, ther might have a correlation between oral somatosensation and food preferences, subsequently influencing eating behavior and food consumption. A standard method, using a so-called Von Frey Hair monofilament, to assess tactile sensation was developed by Etter et al. (Etter, N. M et al.,. J. Vis. Exp. 2020) but has so far been only minimally used in Ear, Nose and Throat (ENT) cancer (Bearelly, Wang, \& Cheung, 2017; Bodin, Jäghagen, \& Isberg, 2004; Elfring, Boliek, Seikaly, Harris, \& Rieger, 2012).
The aim of the study is to determine the variability and role of somatosensory perception (texture, pungency transmitted through the trigeminal system, and temperature) on food preferences in cancer patients compared to healthy volunteers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Somesthesia in Cancer Patients: Variability and Influence on Eating Experience
NCT06803381
CAncer, NUtrition and Taste 2
NCT05027490
Effects of Nutritional Counseling on Nutritional Status and Quality of Life of Head and Neck Cancer Patients
NCT03114202
CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients
NCT04235153
Nutritional Intervention in Geriatric Oncology
NCT00459589
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
head and neck cancer patients with radiotherapy AND chemotherapy
patients included for a head and neck cancer and treated by radiotherapy (+/- surgery) + chemotherapy
Sensorial tests
Patients will be included in the study between 3 to 6 months after the end of treatment and go to the Paul Bocuse Research Institute to perform several sensorial tests. The same sensorial tests will be completed by healthy volunteers to compare.
food preferences questionnaires
Patients will be included in the study between 3 to 6 months after the end of treatment and go at Institut Paul Bocuse to complete food preferences questionnaires. The same questionnaires will be completed by healthy volunteers to compare.
head and neck cancer patients with radiotherapy only
patients included for a head and neck cancer and treated by radiotherapy (+/- surgery) without chemotherapy
Sensorial tests
Patients will be included in the study between 3 to 6 months after the end of treatment and go to the Paul Bocuse Research Institute to perform several sensorial tests. The same sensorial tests will be completed by healthy volunteers to compare.
food preferences questionnaires
Patients will be included in the study between 3 to 6 months after the end of treatment and go at Institut Paul Bocuse to complete food preferences questionnaires. The same questionnaires will be completed by healthy volunteers to compare.
healthy volunteers
healthy volunteers paired with experimental patients on age (+/- 5 years), gender, tobacco status
Sensorial tests
Patients will be included in the study between 3 to 6 months after the end of treatment and go to the Paul Bocuse Research Institute to perform several sensorial tests. The same sensorial tests will be completed by healthy volunteers to compare.
food preferences questionnaires
Patients will be included in the study between 3 to 6 months after the end of treatment and go at Institut Paul Bocuse to complete food preferences questionnaires. The same questionnaires will be completed by healthy volunteers to compare.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sensorial tests
Patients will be included in the study between 3 to 6 months after the end of treatment and go to the Paul Bocuse Research Institute to perform several sensorial tests. The same sensorial tests will be completed by healthy volunteers to compare.
food preferences questionnaires
Patients will be included in the study between 3 to 6 months after the end of treatment and go at Institut Paul Bocuse to complete food preferences questionnaires. The same questionnaires will be completed by healthy volunteers to compare.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Person between 18 and 65 years
* Person having given free, informed, express written consent
* Person affiliated to a French social security system
* Person with a body mass superior to 18 kg/m².
* Person able to come once to the Institut Paul Bocuse
Patients with head and neck cancer with chemotherapy:
\- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiochemotherapy or radiochemotherapy alone
Patients with head and neck cancer without chemotherapy:
\- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiation therapy or radiation therapy alone
Healthy volunteers :
* Volunteer who is +/- 5 years of age relative to the patient to whom they are matched.
* Volunteer of the same sex as the patient to whom they are matched
* Volunteer with the same smoking status as the patient to whom they are matched
* Volunteer who has not had cancer within 5 years at the time of inclusion
* Volunteer with no current treatment that may affect taste and smell perception
Exclusion Criteria
* Person with a known food allergy/intolerance (lactose or milk protein) or unable to consume dairy or solid products (e.g., chocolate milk pudding, chocolate jelly)
* Person with a known allergy to chili (or capsaicin)
* Person with diagnosed total ageusia
* Person with diagnosed total anosmia
* Person who has used artificial feeding within 2 months prior to inclusion.
* Person who has lost more than 10% of baseline weight in the 2 months prior to inclusion
* Person deprived of liberty or under guardianship or trusteeship.
* Pregnant or breastfeeding woman
* Person deprived of liberty by a judicial or administrative decision
* Person under guardianship or protection of vulnerable adults
* Person with trismus (reduced jaw opening or limited jaw range of motion)
* A person who is unable to extend his or her tongue
* Person who has had surgery on the mobile tongue and/or base of the tongue
* Person unable to swallow soft foods
* Person who has had or is suspected of having had Corona Virus Disease (COVID)-19 within the last 6 months.
Patients with head and neck cancer:
* Patient receiving immunotherapy
* Patient treated with surgery only.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amandine BRUYAS
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de recherche de l'Institut Paul Bocuse
Écully, , France
Service d'Oncologie médicale, Hôpital de la Croix-Rousse
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Riantiningtyas RR, Valenti A, Dougkas A, Bredie WLP, Kwiecien C, Bruyas A, Giboreau A, Carrouel F. Oral somatosensory alterations and salivary dysfunction in head and neck cancer patients. Support Care Cancer. 2023 Oct 13;31(12):627. doi: 10.1007/s00520-023-08086-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL21_1153
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.